Ted Okon, MBA, expresses concern that as state healthcare innovation plans develop, there may be a lack of collaboration among states in the sharing of data. To be successful, data exchange is vital, he says.
On the topic of quality measures, Mr Okon adds that without collaboration among states, different states will have different quality measures. He advises that whether implemented at a state level or at the federal level, the same measures must be used. The quality measures that have been established following the development of new payments models under the Affordable Care Act do not have much bearing with regard to oncology care, comment both Michael Kolodziej, MD, and Mr Okon.
Mr Okon explains that several variations of the Accountable Care Organization (ACO) model have been established. Although these models are a “head start” in leading innovation, he suggests that there are fundamental problems that need to be addressed. Specifically, the quality measures established for Medicare ACOs launched by Medicare do not pertain to routine cancer care, notes Mr Okon, and that instead of allowing the federal government to dictate quality measures, input from providers and patients is necessary when addressing these challenges.
Aetna is partnering with several provider systems with regard to ACO models, Dr Kolodziej remarks. He explains that Medicare’s projections for the number of patients they would like to enroll in alternative payment programs are aggressive, and adds that Aetna is working in parallel with Medicare and the new ACO payment models.
Watch our related Peer Exchange, Oncology Stakeholders Summit, Spring 2015
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More